Immune checkpoint inhibitors and cellular treatment for lymphoma immunotherapy

Li, F; Chen, Y; Pang, M; Yang, P; Jing, H

Jing, H (corresponding author), Peking Univ Third Hosp, Dept Hematol, 49 Huayuan North Rd, Beijing 100191, Peoples R China.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2021; 205 (1): 1

Abstract

Malignant lymphoma (ML) is a common hematological malignancy with many subtypes. Patients with ML usually undergo traditional treatment failure and be......

Full Text Link